Heart failure - Nursing Case Study
Pathophysiology
• Primary mechanism: Reduced cardiac output due to impaired ventricular function, often from myocardial damage (e.g., ischemic heart disease), limits blood flow and oxygen delivery to tissues, leading to fatigue and exercise intolerance.
• Secondary mechanism: Compensatory neurohormonal activation, notably the renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system, initially maintains perfusion but eventually exacerbates fluid retention and increases cardiac workload, worsening heart failure.
• Key complication: Chronic fluid overload causes pulmonary congestion and peripheral edema, leading to symptoms like dyspnea and swelling, which are critical for nurses to monitor and manage in patient care.
Patient Profile
Demographics:
62-year-old male, retired construction worker
History:
• Key past medical history: Hypertension, type 2 diabetes, previous myocardial infarction
• Current medications: Lisinopril, Metformin, Aspirin, Furosemide
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing shortness of breath and fatigue
• Key symptoms: Dyspnea on exertion, peripheral edema, orthopnea, occasional chest discomfort
• Vital signs: Blood pressure 145/90 mmHg, heart rate 105 bpm, respiratory rate 22 breaths per minute, oxygen saturation 90% on room air, temperature 98.6°F
Section 1
The nursing team conducts an initial assessment of the patient, focusing on his respiratory and cardiovascular systems given his chief complaints and medical history. Upon auscultation, bilateral crackles are noted in the lower lung fields, indicating pulmonary congestion likely due to fluid overload. The jugular venous pressure is elevated, suggesting increased central venous pressure consistent with right-sided heart failure. Peripheral edema is observed, with pitting noted up to the knees. The patient reports using two pillows at night to alleviate shortness of breath, although he still experiences episodes of orthopnea.
Blood tests reveal a brain natriuretic peptide (BNP) level of 800 pg/mL, significantly elevated and indicative of heart failure exacerbation. Electrolyte imbalances are noted, with a serum potassium level of 3.2 mEq/L, which is lower than normal and potentially exacerbated by the diuretic therapy. An echocardiogram is scheduled to evaluate left ventricular ejection fraction and assess any changes in cardiac structure or function since his last evaluation post-myocardial infarction. The nurse considers the implications of these findings, including the need to adjust the patient’s diuretic therapy, address the electrolyte imbalance, and possibly increase the dosage of the ACE inhibitor to reduce afterload and improve cardiac output.
As the patient continues to experience increased fatigue and dyspnea, the healthcare team evaluates his current medication regimen and considers the initiation of a beta-blocker to further manage heart failure symptoms and reduce myocardial oxygen demand. The interdisciplinary team discusses the importance of ongoing monitoring and adjustment of treatment to prevent further complications such as arrhythmias or worsening renal function. The nurse plans to educate the patient on recognizing early signs of fluid overload and the importance of adherence to dietary restrictions, particularly sodium intake, to manage his condition more effectively.
Section 2
As the patient's condition unfolds, the healthcare team notices a change in his status. Despite initial interventions to manage the heart failure symptoms, the patient's respiratory distress appears to be worsening. He now requires three pillows at night to relieve orthopnea and reports increased shortness of breath with minimal exertion. Vital signs show a blood pressure of 150/85 mmHg, a heart rate of 110 beats per minute, and an increased respiratory rate of 26 breaths per minute. Oxygen saturation has decreased to 90% on room air, prompting the need for supplemental oxygen therapy. Additionally, the patient exhibits mild cyanosis of the lips and extremities, suggesting decreased peripheral oxygenation.
A repeat set of laboratory tests reveals worsening renal function, with a serum creatinine level escalating to 2.5 mg/dL from a baseline of 1.8 mg/dL, indicative of potential renal impairment, possibly exacerbated by diuretic therapy. The serum potassium remains low at 3.0 mEq/L, raising concerns about the risk of arrhythmic events. Given these findings, the interdisciplinary team considers the need for cautious adjustment of medications, including a potential reduction in the diuretic dose to mitigate further renal compromise, while addressing the electrolyte imbalance through potassium supplementation.
The team's clinical reasoning now focuses on balancing the management of fluid overload with the prevention of further renal deterioration. The nurse collaborates with the team to reassess the patient's fluid status and initiate plans for closer monitoring of renal function and electrolytes. Additionally, the patient is educated on the importance of reporting new symptoms promptly and adhering to medication and dietary guidelines. The nurse emphasizes the significance of low-sodium diets and fluid restriction in preventing further exacerbations, setting the stage for potential adjustments in the patient's care plan and preparing for possible escalation of interventions if the patient's status does not improve.
Section 3
As the healthcare team continues to monitor the patient's condition, a new complication emerges. Overnight, the patient's respiratory distress escalates, and he begins to experience paroxysmal nocturnal dyspnea, waking with sudden feelings of suffocation. Despite the supplemental oxygen therapy, his oxygen saturation remains borderline at 92% with 2 liters of oxygen via nasal cannula. On auscultation, bilateral crackles at the lung bases become more pronounced, indicating worsening pulmonary congestion. The patient's vital signs indicate persistent tachycardia with a heart rate of 115 beats per minute and a slightly elevated blood pressure of 155/90 mmHg, despite ongoing antihypertensive therapy.
The team orders an urgent chest X-ray and echocardiogram to further assess the cardiac function and pulmonary status. The chest X-ray reveals increased pulmonary vascular markings and mild pleural effusion bilaterally, suggestive of progressive heart failure. The echocardiogram shows a reduced ejection fraction of 35%, indicating significant left ventricular dysfunction. These findings prompt the team to reconsider the current management strategy, balancing the need for aggressive diuresis with the risk of further renal impairment.
Given the new diagnostic results, the interdisciplinary team decides to initiate a low-dose inotropic agent to support cardiac output and consider an adjustment in the diuretic regimen to better manage fluid overload while minimizing renal strain. The nurse plays a crucial role in educating the patient and family about the importance of adherence to the revised medication plan and dietary restrictions, emphasizing the need for regular follow-up and monitoring. The team also discusses the potential need for advanced therapies, such as consideration for device implantation or further cardiology consultation, if the patient's status does not stabilize with the current interventions.
Section 4
As the patient continues under close observation, the healthcare team notes a change in his status indicating new complications. Over the next 24 hours, despite the initiation of a low-dose inotropic agent and adjusted diuretic regimen, the patient develops signs of worsening renal function. His urine output decreases significantly, dropping to less than 20 mL/hour, and laboratory results show rising serum creatinine levels, now at 2.1 mg/dL, compared to a baseline of 1.3 mg/dL. The blood urea nitrogen (BUN) also increases, suggesting acute kidney injury likely exacerbated by aggressive diuresis and underlying heart failure.
In light of these developments, the team faces a clinical conundrum: the need to manage fluid overload while preserving renal function. A nephrology consultation is sought to evaluate the potential for renal protective strategies, which might include the consideration of switching to a more renal-friendly diuretic or incorporating renal replacement therapy if indicated. The patient’s fluid balance is reassessed, and strict input-output monitoring is reinforced to ensure optimal management of fluid status.
The nurse plays a pivotal role in this phase, carefully monitoring the patient's response to therapy and educating him and his family about the signs and symptoms of worsening renal function and fluid overload. The nurse also ensures the patient understands the importance of adhering to the fluid and sodium restrictions, given the delicate balance required to manage both heart failure and renal function effectively. This scenario sets the stage for further clinical decisions, including possible adjustments in the pharmacological approach or consideration of advanced therapies, depending on the patient's response to the current interventions.
Section 5
As the healthcare team continues to monitor the patient, the initial assessment findings reveal a concerning change in his cardiovascular and renal status. The patient's blood pressure has decreased to 88/58 mmHg, and he exhibits signs of peripheral edema with swelling noted in the lower extremities. Auscultation of the lungs reveals crackles at the bases, indicating persistent pulmonary congestion despite the current diuretic therapy. The patient also reports increased shortness of breath and fatigue, struggling with basic activities such as sitting up in bed.
In response to these findings, the team orders a series of diagnostic tests to further elucidate the patient's condition. A repeat echocardiogram is performed, revealing a reduced ejection fraction of 30%, down from 35% noted in a prior study. This worsening left ventricular function raises concerns about the adequacy of the inotropic support. A renal ultrasound is conducted to assess for any structural abnormalities contributing to the acute kidney injury, with results pending. The serum electrolyte panel shows hyponatremia with a sodium level of 129 mEq/L, complicating the fluid management strategy.
Given the patient's hemodynamic instability and the evidence of worsening heart and renal function, the healthcare team deliberates on the next steps. There is a growing consensus on the need to adjust the pharmacological approach, potentially incorporating vasopressor support to stabilize blood pressure while cautiously managing fluid status. The nephrology team recommends initiating low-dose dopamine to enhance renal perfusion, considering the patient's delicate balance between cardiac output and renal function. The patient and his family are informed of the evolving situation, emphasizing the critical nature of the interventions and the importance of close adherence to the outlined treatment plan. This collaborative approach sets the stage for the next phase of care, as the team remains vigilant for further changes in the patient's condition.